HI
OLMA icon

Harbour Investments’s Olema Pharmaceuticals OLMA Stock Holding History

Harbour Investments’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320 Buy
26
+16
+160% +$214 ﹤0.01% 4451
2026
Q1 		$162 Buy
+10
New +$223 ﹤0.01% 4467

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Harbour Investments's OLMA Position: Q2 2026 in Review

Harbour Investments increased its Olema Pharmaceuticals (OLMA) stake by 160% in Q2 2026, buying an estimated $214 and bringing the position to 26 shares worth $320. The position accounts for ﹤0.01% of the portfolio, ranked #4451.

Harbour Investments first reported a position in OLMA in Q1 2026 and has held it in 2 quarters since. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Harbour Investments held 26 shares of Olema Pharmaceuticals worth $320 as of Q2 2026.
  • Harbour Investments bought 16 Olema Pharmaceuticals shares in Q2 2026, an estimated $214.
  • Olema Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4451 holding.
  • Harbour Investments first reported a position in Olema Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.